ECG Findings in Dilated Cardiomyopathy (DCM)
The electrocardiogram (ECG) in dilated cardiomyopathy is abnormal in nearly 100% of cases and may show characteristic findings including left bundle branch block, T-wave inversions, left atrial enlargement, and low voltage QRS complexes. 1
Common ECG Abnormalities in DCM
Left Bundle Branch Block (LBBB): Present in approximately 30-40% of DCM patients and is the second most common ECG finding. LBBB represents dyssynchronous left ventricular activation and is often associated with more advanced disease 1, 2
T-wave inversions: Commonly seen in the lateral and inferior leads, representing repolarization abnormalities 1
Intraventricular conduction defects: Widened QRS complexes (>110 ms) are frequently observed, even without complete bundle branch block 1
Left atrial enlargement: Present in approximately 47.5% of patients, reflecting the hemodynamic consequences of LV dysfunction 3
Prolonged PR interval: First-degree AV block is seen in about 27.5% of cases 3
Abnormal Q waves: Present in approximately 15-19% of patients, particularly in the inferior and/or lateral leads, which may be confused with prior myocardial infarction 1, 3
Low voltage QRS complexes: Particularly common in advanced disease 1, 4
Fragmented QRS complexes: A marker of depolarization abnormality associated with arrhythmic events and intraventricular dyssynchrony 2
Specific ECG Patterns in DCM
Predominant S waves in V2-V4: This is the most frequent characteristic pattern (34.4% of cases), often coexisting with lack of R wave progression from V1 to V4 4
QS pattern with elevated ST segments: Present in approximately 15.5% of cases, betraying extensive areas of fibrosis or necrosis, typically located at the apex and associated with ventricular tachycardia 4
Normal QRS shape with ST-T abnormalities: Seen in about 12.2% of cases, showing that repolarization is highly sensitive to alterations in the subendocardial layers 4
Genotype-Specific ECG Findings
Lamin A/C mutations: Often present with first-degree AV block and pathological Q waves in the inferior and/or lateral leads 1
Dystrophin mutations: May show similar ECG patterns to Lamin A/C mutations with conduction abnormalities 1
Arrhythmias in DCM
Ventricular arrhythmias: Present in approximately 30% of DCM patients, even with only mildly dilated LV cavity 1
Atrial arrhythmias: Supraventricular tachycardias are common, especially in advanced disease 1
Sinus tachycardia: A common finding, particularly in later stages of the disease 1
Prognostic Implications
QRS duration: Prolonged QRS duration is associated with worse outcomes and higher mortality 2
Left ventricular conduction delays: Associated with worse prognosis 3
QT dispersion: Can identify patients at greatest risk for cardiac death 1
Examples of DCM ECG Patterns
Classic DCM pattern: LBBB with poor R wave progression, left axis deviation, and nonspecific ST-T wave changes 1
Early DCM: May show only subtle changes such as nonspecific ST-T wave abnormalities with normal QRS duration 5
Advanced DCM: Low voltage QRS complexes, LBBB, left atrial enlargement, and frequent ventricular ectopy 3, 4
Clinical Implications
ECG abnormalities may precede overt structural changes and can be the first sign of disease in approximately 25% of cases 3
Serial ECG changes, particularly increasing left ventricular conduction delay and leftward shifting of the QRS axis, may indicate disease progression 3
The presence of specific ECG patterns may help identify genetic subtypes of DCM, particularly in familial cases 1, 5
ECG findings should be interpreted in conjunction with imaging studies (echocardiography, cardiac MRI) for comprehensive evaluation 1
Monitoring Recommendations
All DCM patients should have an initial cardiac evaluation with ECG at diagnosis 1
Asymptomatic DCM patients <10 years of age should have ECG evaluation every 2 years, increasing to annual evaluation after age 10 1
Patients with LV dysfunction, dilation, or arrhythmias should be reevaluated at least annually 1
Ambulatory ECG monitoring is recommended for risk stratification, particularly in patients with LVEF <30-35% or age ≥17 years 1